cover of episode Legislators Introduce Bipartisan Bills to Break Up Drug Middlemen

Legislators Introduce Bipartisan Bills to Break Up Drug Middlemen

2024/12/11
logo of podcast WSJ What’s News

WSJ What’s News

People
A
Alex Ossola
H
Harriet Torrey
J
Joe Hoppe
L
Liz Esley Whyte
M
Mariah Timms
Topics
Alex Ossola: 本期节目主要报道了FBI局长克里斯托弗·雷在总统大选前辞职,两党议员提出的旨在拆分药房福利管理机构(PBM)的法案,以及11月份通货膨胀上升对美联储的影响。还报道了其他新闻,包括两家大型超市运营商之间的法律纠纷,两名顶级房地产经纪人被捕,以及咖啡价格上涨等。 Harriet Torrey: 11月份消费者物价指数上涨,表明消费者支出强劲,通货膨胀依然存在,尤其是在住房和医疗服务等领域。尽管如此,美联储和投资者对通货膨胀趋势总体持乐观态度,预计美联储将在12月降息。但商品价格的回升是美联储需要关注的潜在风险。特朗普政府的政策也可能加剧通货膨胀。 Liz Esley Whyte: 两党议员提出的法案旨在拆分药房福利管理机构(PBM),迫使拥有保险公司或PBM的公司出售其药房业务。这将对CVS Health、Cigna和UnitedHealth Group等公司造成重大打击。该法案旨在解决PBM的激励机制问题,防止患者被引导到利润更高的邮购药房。PBM改革多年来一直是两党关注的焦点,这项法案是迄今为止对PBM最广泛的干预。 Mariah Timms: 前总统特朗普试图将自己从佐治亚州的案件中移除,理由是总统豁免权。案件的未来尚不确定,可能面临撤销指控或推迟到2029年再审理的可能性。案件长期搁置对起诉方不利,但如果现任检察官继续负责,并且获得批准,案件仍然有可能恢复进展。 Joe Hoppe: 阿拉比卡咖啡豆价格今年上涨超过80%,达到历史新高,主要原因是巴西遭遇了70多年来最严重的干旱,以及越南罗布斯塔咖啡豆产量的下降。 Alex Ossola: This episode covers FBI Director Christopher Wray's resignation before the presidential inauguration, bipartisan bills aimed at breaking up Pharmacy Benefit Managers (PBMs), and the impact of rising inflation in November on the Federal Reserve. Other news includes a legal dispute between two major supermarket operators, the arrest of two top real estate agents, and rising coffee prices.

Deep Dive

Key Insights

Why are legislators introducing bills to break up pharmacy benefit managers (PBMs)?

The bills aim to address the perceived perverse incentives in the PBM industry, such as steering patients to mail-order pharmacies that benefit the PBMs financially, leading to higher costs for consumers.

What are the key proposals in the bipartisan bills targeting PBMs?

The legislation would force companies that own both insurers and PBMs to sell off their pharmacy businesses, including retail, mail-order, and specialty pharmacies, affecting major players like CVS Health, Cigna, and UnitedHealth Group.

What role do pharmacy benefit managers (PBMs) play in the healthcare system?

PBMs create formularies, prioritize drugs for specific diseases, and negotiate discounts and rebates on drugs, aiming to save employers and consumers money by securing better deals on medications.

How could the proposed legislation impact PBMs and consumers?

If passed, the legislation could end practices like steering patients to mail-order pharmacies that benefit PBMs financially, potentially reducing costs for consumers and eliminating conflicts of interest.

What does the bipartisan support for PBM reform indicate about its chances of passing?

The bipartisan support suggests growing interest in addressing healthcare costs and populist concerns, increasing the likelihood that Congress may finally pass significant PBM reform legislation.

What was the key finding in the November inflation report?

The consumer price index rose 2.7% year-over-year and 0.3% month-over-month, marking the strongest monthly increase since April, driven by higher vehicle prices and persistent inflation in housing and services.

How might the November inflation data influence the Federal Reserve's decisions?

The data shows persistent inflation, particularly in services, which the Fed has been trying to contain. While the trend is encouraging, the Fed will monitor rising goods prices, which could complicate their efforts to bring inflation back to target.

Why have coffee prices surged to record highs?

Coffee prices, particularly for Arabica beans, have surged due to severe droughts and heavy rains in Brazil, the largest exporter of Arabica, and reduced production in Vietnam, the largest Robusta producer, leading to supply concerns.

Chapters
Legislators introduced bipartisan bills aiming to break up pharmacy benefit managers (PBMs). This would be the most significant intervention in PBM operations to date, addressing concerns about high drug costs and potential conflicts of interest. The success of these bills remains uncertain, although bipartisan support suggests a possibility of progress.
  • Bipartisan bills introduced in Senate and House to reform PBMs
  • Legislation would force companies owning insurers or PBMs to divest pharmacy businesses
  • Aims to address concerns about high drug costs and potential conflicts of interest
  • Significant bipartisan support, but past attempts failed

Shownotes Transcript

P.M. Edition for Dec. 11. Bills introduced) in the Senate and House seek to break up pharmacy-benefit managers, or PBMs. WSJ reporter Liz Essley Whyte) explains what that could mean for companies and for consumers. And U.S. inflation ticked up last month). Wall Street Journal economics reporter Harriet Torry) clues us in on what that might mean for the Fed when it meets next week. Plus, FBI Director Christopher Wray steps down) before President-elect Donald Trump takes office. Alex Ossola hosts.

Sign up for the WSJ's free What's News newsletter).

Learn more about your ad choices. Visit megaphone.fm/adchoices)